MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
MANGOCEUTICALS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.28−0.01 (-3.38%)
Close on Oct 19, 2026
- Market cap
- $4.80M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$2.1099 (−88.28%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
MANGOCEUTICALS, INC. saw revenue fall 38.9% to $315.23K over the twelve months to Jun 30, 2026.
Revenue
$315.23K
-38.9% vs. a year earlier
Operating income
-$12.07M
TTM Q2 2026
EPS, diluted
-$1.22
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $4.80M
- P/E ratio
- –
- Price to sales
- 15.21
- Price to book
- 0.38
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $315.23K
- Net income
- -$15.10M
- EPS, diluted
- -$1.22
- Book value per share
- $0.73
- Diluted shares
- 17M
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Revenue
$315.23K-38.9% YoY
Gross profit
$171.59K-45.5% YoY
Operating income
-$12.07M
Net income
-$15.10M
EPS, diluted
-$1.22
Free cash flow
–
Reported periodTrailing twelve months